Cullinan Therapeutics Inc
CGEM
NASDAQ
Biotechnology
$20.34
USD
+0.70 (+3.56%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $1.26B
Volume 565.5K
Price Target
$30.00 – $38.00
USD
The 3 analysts offering 1-year price forecasts have a max estimate of $38.00 and a min estimate of $30.00.
Past 2Y
1Y Forecast
Price Targets
Average Target
$35.00
+$0.5 vs prior
Implied Upside
+72.1%
+2.4% vs prior
Analyst Covering
3
-1 vs prior period
Consensus
Buy
Unchanged vs prior
Signal Quality
Consensus Freshness
43%
A mix of recent and older ratings shape this consensus
Analyst Agreement
Moderate
Targets show moderate spread across analysts
Mean vs Median
$2.00 Gap
Median $37.00 vs avg $35.00 - a few cautious outliers are pulling the average down
Analyst Consensus
Strong Sell
Hold
Strong Buy
Buy
3 Buy
0 Hold
0 Sell
Rating Breakdown
Strong Buy
0
Buy
3
Hold
0
Sell
0
Strong Sell
0
3 analysts · last 3 months
Covering Analysts
Unlock each analyst's profile, success rate + price targets
Free shows the consensus and each analyst's current rating.
| Analyst | Firm | Rating | Action | Date | Success Rate | Price Target | Implied Upside |
|---|---|---|---|---|---|---|---|
Robert Driscoll | Wedbush | Buy | Reiterated | 2 months ago | Plus | Plus | Plus |
Robert Burns | HC Wainwright & Co. | Buy | Reiterated | 2 months ago | Plus | Plus | Plus |
Julian Harrison | BTIG | Buy | Reiterated | 2 months ago | Plus | Plus | Plus |
Frequently Asked Questions
Similar Stocks
AKTS
Aktis Oncology Inc
$24.93
▲ +4.8%
PURR
Hyperliquid Strategies Inc
$6.68
▼ -2.0%
MNKD
MannKind Corp
$3.85
▲ +3.2%
INBX
Inhibrx Biosciences Inc
$88.37
▼ -8.9%
NVAX
Novavax Inc
$8.05
▼ -1.1%
MGTX
MeiraGTx Holdings PLC
$13.52
▲ +6.7%
REPL
Replimune Group Inc
$14.97
▼ -1.4%
CRVS
Corvus Pharmaceuticals Inc
$14.89
▼ -1.6%
GLUE
Monte Rosa Therapeutics Inc
$15.50
▼ -2.1%